Cannabis finance news

Cronos Australia and CDA Health agree merger deal

by Hannah Adler September 14, 2021April 26, 2024

Cronos Australia and CDA Health have agreed to merge, subject to shareholder approval. Cronos Australia has […]

Report finds sales of three major cannabis pharmaceutical products set to reach EU$1.8 billion by 2025

by Hannah Adler September 6, 2021April 26, 2024

Roby Zomer

Company news: MGC Pharma; Emyria; ECS Botanics; Rua Bioscience; AusCann; Cannasouth; Cronos; Althea

by Martin Lane September 2, 2021April 26, 2024

ONJ Foundation

Cann Global deal to bring Olivia’s Choice cannabis formula to Australia hits regulatory buffers

by Steve Jones September 2, 2021April 26, 2024

New Zealand medicinal cannabis company Organic Genetics starts crowdfunding campaign

by Hannah Adler September 1, 2021April 26, 2024

Creso Pharma’s merger with Red Light Holland is off

by Martin Lane September 1, 2021April 26, 2024

Operational losses narrow at LGP as revenue climbs to more than A$7m

by Steve Jones September 1, 2021April 26, 2024

Company news: Bod; Emyria; Cann Group; Health House; Releaf Clinics; Creso Pharma; Greenfern; Medlab

by Martin Lane August 26, 2021April 26, 2024

josh fegan

Althea completes A$10.64m capital raise and sets sights on ‘material growth’

by Steve Jones August 25, 2021April 26, 2024

Company news: TCann; ECS Botanics; Cannaponics; Releaf Group; Cannvalate; Elixinol; Creso Pharma; Incannex

by Martin Lane August 19, 2021April 26, 2024